Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Cardiovascular Research
|
November 26, 2008
Phosphodiesterase 5 inhibition blocks pressure overload-induced cardiac hypertrophy independent of the calcineurin pathway
Steven Hsu, Takahiro Nagayama, Norimichi Koitabashi, et al.
Frontiers in Physiology
|
November 19, 2019
MiR-29 Regulates <i>de novo</i> Lipogenesis in the Liver and Circulating Triglyceride Levels in a Sirt1-Dependent Manner
Yu-Han Hung, Matt Kanke, Catherine Lisa Kurtz, et al.
Oncotarget
|
February 10, 2018
Cancer immunogenomic approach to neoantigen discovery in a checkpoint blockade responsive murine model of oral cavity squamous cell carcinoma
Paul Zolkind, Dariusz Przybylski, Nemanja Marjanovic, et al.
Physiological Genomics
|
June 29, 2019
Acute suppression of insulin resistance-associated hepatic miR-29 in vivo improves glycemic control in adult mice
Yu-Han Hung, Matt Kanke, C Lisa Kurtz, et al.
Anesthesiology
|
December 26, 2024
Covert Perioperative Strokes in Older Patients Having Noncardiac Surgery (PRECISION): A Prospective Cohort Analysis
Qianyu Cui, Weixing Zhao, Hongyan Chen, et al.
Nucleic Acids Research
|
September 17, 2021
TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response
Zexian Zeng, Cheryl J Wong, Lin Yang, et al.
Journal for Immunotherapy of Cancer
|
January 21, 2022
Checkpoint blockade-induced CD8+ T cell differentiation in head and neck cancer responders
Liye Zhou, Zexian Zeng, Ann Marie Egloff, et al.
Science Immunology
|
September 8, 2023
Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancer
Giacomo Oliveira, Ann Marie Egloff, Alexander B Afeyan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 16, 2020
Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial
Ravindra Uppaluri, Katie M Campbell, Ann Marie Egloff, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Cardiovascular Research
|
November 26, 2008
Phosphodiesterase 5 inhibition blocks pressure overload-induced cardiac hypertrophy independent of the calcineurin pathway
Steven Hsu, Takahiro Nagayama, Norimichi Koitabashi, et al.
Frontiers in Physiology
|
November 19, 2019
MiR-29 Regulates <i>de novo</i> Lipogenesis in the Liver and Circulating Triglyceride Levels in a Sirt1-Dependent Manner
Yu-Han Hung, Matt Kanke, Catherine Lisa Kurtz, et al.
Oncotarget
|
February 10, 2018
Cancer immunogenomic approach to neoantigen discovery in a checkpoint blockade responsive murine model of oral cavity squamous cell carcinoma
Paul Zolkind, Dariusz Przybylski, Nemanja Marjanovic, et al.
Physiological Genomics
|
June 29, 2019
Acute suppression of insulin resistance-associated hepatic miR-29 in vivo improves glycemic control in adult mice
Yu-Han Hung, Matt Kanke, C Lisa Kurtz, et al.
Anesthesiology
|
December 26, 2024
Covert Perioperative Strokes in Older Patients Having Noncardiac Surgery (PRECISION): A Prospective Cohort Analysis
Qianyu Cui, Weixing Zhao, Hongyan Chen, et al.
Nucleic Acids Research
|
September 17, 2021
TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response
Zexian Zeng, Cheryl J Wong, Lin Yang, et al.
Journal for Immunotherapy of Cancer
|
January 21, 2022
Checkpoint blockade-induced CD8+ T cell differentiation in head and neck cancer responders
Liye Zhou, Zexian Zeng, Ann Marie Egloff, et al.
Science Immunology
|
September 8, 2023
Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancer
Giacomo Oliveira, Ann Marie Egloff, Alexander B Afeyan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 16, 2020
Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial
Ravindra Uppaluri, Katie M Campbell, Ann Marie Egloff, et al.
Page
of 4